Chandra Tulika, Rizvi S Nishat Fatima, Agarwal Devisha
Department of Transfusion Medicine and Blood Bank, King George's Medical University, Lucknow, Uttar Pradesh 226003, India.
ScientificWorldJournal. 2014 Jan 27;2014:173939. doi: 10.1155/2014/173939. eCollection 2014.
Transfusion transmitted infections are major problem associated with blood transfusion. Accurate estimates of risk of TTIs are essential for monitoring the safety of blood supply and evaluating the efficacy of currently employed screening procedures. The present study was carried out to assess the percentage of voluntary donors and replacement donors and to find out prevalence and changing trends of various TTIs blood donors in recent years. A study was carried out on blood units of voluntary and replacement donors which were collected from January 2008 to December 2012. On screening of 180,371 replacement units, seropositivity of transfusion transmitted disease in replacement donors was 0.15% in HIV, 1.67% in hepatitis B surface antigen, 0.49% in hepatitis C virus, 0.01% in VDRL, and 0.009% in malaria. Of 11,977 voluntary units, seropositivity of transfusion transmitted disease in voluntary donors was 0.08% in HIV, 0.24% in hepatitis B surface antigen, 0.001% in hepatitis C virus, 0.008% in VDRL (sexually transmitted disease), and 0.01% in malaria. From results it has been concluded that prevalence of transfusion transmitted infection (HIV, HBV, HCV, VDRL, and malaria) was more in replacement donors in comparison to voluntary donors. Extensive donor selection and screening procedures will help in improving the blood safety.
输血传播感染是与输血相关的主要问题。准确估计输血传播感染的风险对于监测血液供应的安全性以及评估当前所采用筛查程序的效果至关重要。本研究旨在评估无偿献血者和替代献血者的比例,并了解近年来各类输血传播感染在献血者中的流行情况及变化趋势。对2008年1月至2012年12月期间采集的无偿献血者和替代献血者的血液样本进行了一项研究。在对180,371份替代献血者的血液样本进行筛查时,替代献血者中输血传播疾病的血清学阳性率分别为:HIV为0.15%,乙肝表面抗原为1.67%,丙型肝炎病毒为0.49%,梅毒为0.01%,疟疾为0.009%。在11,977份无偿献血者的血液样本中,无偿献血者中输血传播疾病的血清学阳性率分别为:HIV为0.08%,乙肝表面抗原为0.24%,丙型肝炎病毒为0.001%,梅毒(性传播疾病)为0.008%,疟疾为0.01%。从结果可以得出结论,与无偿献血者相比,替代献血者中输血传播感染(HIV、HBV、HCV、梅毒和疟疾)的流行率更高。广泛的献血者选择和筛查程序将有助于提高血液安全性。